(Q42803511)

7 November 2017

Characterization of new PPARgamma agonists: analysis of telmisartan's structural components (English)

1 reference

7 November 2017

3

1 reference

7 November 2017

4

Thomas Unger

1 reference

7 November 2017

5

Ulrich Kintscher

1 reference

7 November 2017

2

Markus Clemenz

1 reference

7 November 2017

6

Ronald Gust

1 reference

7 November 2017

Matthias Goebel

1

1 reference

7 November 2017

1 March 2009

1 reference

7 November 2017

1 reference

7 November 2017

4

1 reference

7 November 2017

3

1 reference

7 November 2017

445-456

1 reference

The PPARs: from orphan receptors to drug discovery

7 November 2017

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

The mechanisms of action of PPARs

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

The nuclear receptor superfamily: the second decade

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

A unified nomenclature system for the nuclear receptor superfamily

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

Peroxisome proliferator-activated receptor agonists.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

Molecular characterization of new selective peroxisome proliferator-activated receptor gamma modulators with angiotensin receptor blocking activity

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

Conversion of sterically hindered diacylated 1,2-phenylenediamines into 2-substituted benzimidazoles

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

Prospective identification of biologically active structures by topomer shape similarity searching

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

Regulation of peroxisome proliferator-activated receptor gamma activity by losartan metabolites

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200800285

7 January 2021

Identifiers

DOI

10.1002/CMDC.200800285

1 reference

7 November 2017

1 reference

PubMed ID

19197922